FDA Authorizes First COVID Booster For Kids Ages 5 To 11

The Meals and Drug Management (FDA) has approved the usage of the Pfizer COVID-19 vaccine as a booster for children ages 5 to 11.

The FDA defined the verdict got here on account of extra hospitalizations and long-term results discovered inside kids in contemporary knowledge.

Kids on this age team would possibly now obtain a booster shot once 5 months after their first cycle of vaccinations.

“Whilst it has in large part been the case that COVID-19 has a tendency to be much less critical in kids than adults, the omicron wave has observed extra youngsters getting ill with the illness and being hospitalized, and youngsters may additionally enjoy long run results, even following first of all gentle illness,” FDA Commissioner Robert M. Califf, M.D. mentioned. “The FDA is authorizing the usage of a unmarried booster dose of the Pfizer-BioNTech COVID-19 Vaccine for kids 5 thru 11 years of age to supply endured coverage in opposition to COVID-19.”

In Pfizer/BioNTech’s trials for the booster, 4,500 kids ages 5 to 11 had been noticed and located the unwanted effects had been in keeping with previous doses of the vaccine, with the most typical being ache, redness and swelling on the injection website online, fatigue, complications, muscle or joint ache, chills and fevers.

The CDC licensed the usage of a primary booster for kids ages 12-15 again in January, with the booster being approved for ages 16 and up in November of 2021.

 

Updated: May 19, 2022 — 6:17 am